Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine whether erythrocyte polyglutamate levels are associated
with objective clinical response in patients with rheumatoid arthritis after oral
administration of low-dose methotrexate.The secondary aim of this study is to compare the
efficacy and safety of standard dose methotrexate versus a higher starting dose.
Phase:
Phase 4
Details
Lead Sponsor:
Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation